BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3420008)

  • 1. Angiotensin II immunoreactivity in push-pull perfusates from the paraventricular nucleus.
    Doris PA
    Peptides; 1988; 9(3):481-5. PubMed ID: 3420008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Release of vasopressin and oxytocin by paraventricular stimulation in rats.
    Landgraf R; Malkinson T; Horn T; Veale WL; Lederis K; Pittman QJ
    Am J Physiol; 1990 Jan; 258(1 Pt 2):R155-9. PubMed ID: 2301628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo hypothalamic release of thyrotropin-releasing hormone after electrical stimulation of the paraventricular area: comparison between push-pull perfusion technique and collection of hypophysial portal blood.
    Rondeel JM; de Greef WJ; van der Vaart PD; van der Schoot P; Visser TJ
    Endocrinology; 1989 Aug; 125(2):971-5. PubMed ID: 2502381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of septal release of vasopressin and oxytocin by the push-pull technique following electrical stimulation of the paraventricular nucleus of rats.
    Neumann I; Schwarzberg H; Landgraf R
    Brain Res; 1988 Oct; 462(1):181-4. PubMed ID: 3179731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II receptors in paraventricular nucleus, subfornical organ, and pituitary gland of hypophysectomized, adrenalectomized, and vasopressin-deficient rats.
    Castrén E; Saavedra JM
    Proc Natl Acad Sci U S A; 1989 Jan; 86(2):725-9. PubMed ID: 2911602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variations in concentration of oxytocin and vasopressin in the paraventricular nucleus of the hypothalamus during the estrous cycle in rats.
    Greer ER; Caldwell JD; Johnson MF; Prange AJ; Pedersen CA
    Life Sci; 1986 Jun; 38(25):2311-8. PubMed ID: 3724360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arginine vasopressin in hypothalamic paraventricular nucleus is transferred to the caudate nucleus to participate in pain modulation.
    Yang J; Li P; Zhang XY; Zhang J; Hao F; Pan YJ; Lu GZ; Lu L; Wang DX; Wang G; Yan FL
    Peptides; 2011 Jan; 32(1):71-4. PubMed ID: 20965220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arginine vasopressin in hypothalamic paraventricular nucleus is transferred to the nucleus raphe magnus to participate in pain modulation.
    Yang J; Yuan H; Liu W; Song C; Xu H; Wang G; Song C; Ni N; Yang D; Lin B
    Peptides; 2009 Sep; 30(9):1679-82. PubMed ID: 19520128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biorhythm of arginine- vasopressin in the paraventricular, supraoptic and suprachiasmatic nuclei of rats.
    Noto T; Hashimoto H; Doi Y; Nakajima T; Kato N
    Peptides; 1983; 4(6):875-8. PubMed ID: 6687011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Release of angiotensins in paraventricular nucleus of rat in response to physiological and chemical stimuli.
    Harding JW; Jensen LL; Hanesworth JM; Roberts KA; Page TA; Wright JW
    Am J Physiol; 1992 Jan; 262(1 Pt 2):F17-23. PubMed ID: 1733292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of intravenous administration of interleukin-1-beta on the release of prostaglandin E2, corticotropin-releasing factor, and arginine vasopressin in several hypothalamic areas of freely moving rats: estimation by push-pull perfusion.
    Watanobe H; Takebe K
    Neuroendocrinology; 1994 Jul; 60(1):8-15. PubMed ID: 8090286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Norepinephrine regulates arginine vasopressin secretion in hypothalamic paraventricular nucleus relating with pain modulation.
    Yang J; Yuan HF; Liu WY; Zhang XX; Feng JP; Ni N; Yang DW; Song CY; Xu HT; Wang G; Song C; Lin BC
    Neuropeptides; 2009 Aug; 43(4):259-65. PubMed ID: 19573913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic changes in hypothalamic angiotensin II levels and release in association with progesterone-induced luteinizing hormone surge.
    Phillips MI; Wang H; Kimura B; Rejtman M; Koduri P; Kalra SP
    Endocrinology; 1993 Apr; 132(4):1637-42. PubMed ID: 8462463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release of immunoassayable neurohypophyseal peptides from rat spinal cord, in vivo.
    Pittman QJ; Riphagen CL; Lederis K
    Brain Res; 1984 May; 300(2):321-6. PubMed ID: 6145502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of colchicine on the hypothalamo-neurohypophysial system of chronically salt-loaded rats.
    Peña P; Rodríguez EM; Dellmann HD; Schoebitz K
    Neuroendocrinology; 1988 Mar; 47(3):217-24. PubMed ID: 3362303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrahypothalamic perfusion with interleukin-1-beta stimulates the local release of corticotropin-releasing hormone and arginine vasopressin and the plasma adrenocorticotropin in freely moving rats: a comparative perfusion of the paraventricular nucleus and the median eminence.
    Watanobe H; Takebe K
    Neuroendocrinology; 1993 Apr; 57(4):593-9. PubMed ID: 8396215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Release of angiotensin in the paraventricular nucleus in response to hyperosmotic stimulation in conscious rats: a microdialysis study.
    Qadri F; Edling O; Wolf A; Gohlke P; Culman J; Unger T
    Brain Res; 1994 Feb; 637(1-2):45-9. PubMed ID: 8180820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distributions of pro-vasopressin expressing and pro-vasopressin deficient CRH neurons in the paraventricular hypothalamic nucleus of colchicine-treated normal and adrenalectomized rats.
    Whitnall MH
    J Comp Neurol; 1988 Sep; 275(1):13-28. PubMed ID: 3262632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-existence of CRF and vasopressin immunoreactivity in parvocellular paraventricular neurons of rat hypothalamus.
    Piekut DT; Joseph SA
    Peptides; 1986; 7(5):891-8. PubMed ID: 3540910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of peptide histidine-isoleucine/vasoactive intestinal polypeptide-immunoreactive neurons in the central nervous system with special reference to their relation to corticotropin releasing factor- and enkephalin-like immunoreactivities in the paraventricular hypothalamic nucleus.
    Hökfelt T; Fahrenkrug J; Ju G; Ceccatelli S; Tsuruo Y; Meister B; Mutt V; Rundgren M; Brodin E; Terenius L
    Neuroscience; 1987 Dec; 23(3):827-57. PubMed ID: 3125490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.